Physician profile
Eric Pales
NPI 1508938507
$1,136.78
in general payments reported to CMS, 2019-2025
16 companies · $43.41 in 2025
The $43.41 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $124 · 2021: $362 · 2022: $62.15 · 2023: $43.96 · 2024: $168 · 2025: $43.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $347.69 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $148.52 | 2019-2024 | Mounjaro |
| Abbvie INC. | $131.68 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $90.38 | 2019-2021 | |
| Amgen INC. | $61.54 | 2021-2024 | Prolia, Evenity |
| Astrazeneca Pharmaceuticals LP | $60.71 | 2019-2022 | |
| Glaxosmithkline, LLC. | $47.89 | 2019-2020 | |
| Pfizer INC. | $44.67 | 2023-2025 | |
| Seqirus USA INC | $43.22 | 2024 | Fluad, Flucelvax |
| Novartis Pharmaceuticals Corporation | $34.47 | 2019-2021 | |
| Exact Sciences Corporation | $29.03 | 2024 | Cologuard Collection Kit |
| Actelion Pharmaceuticals US, INC. | $24.16 | 2024 | Opsumit, Uptravi |
| Esperion Therapeutics, INC. | $23.20 | 2021 | |
| Philips North America LLC | $18.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.22 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.06 | 2024 | Cuvitru |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.